Circadian lipid synthesis in brown fat maintains murine body temperature during chronic cold
- PMID: 31451658
- PMCID: PMC6744860
- DOI: 10.1073/pnas.1909883116
Circadian lipid synthesis in brown fat maintains murine body temperature during chronic cold
Abstract
Ambient temperature influences the molecular clock and lipid metabolism, but the impact of chronic cold exposure on circadian lipid metabolism in thermogenic brown adipose tissue (BAT) has not been studied. Here we show that during chronic cold exposure (1 wk at 4 °C), genes controlling de novo lipogenesis (DNL) including Srebp1, the master transcriptional regulator of DNL, acquired high-amplitude circadian rhythms in thermogenic BAT. These conditions activated mechanistic target of rapamycin 1 (mTORC1), an inducer of Srebp1 expression, and engaged circadian transcriptional repressors REV-ERBα and β as rhythmic regulators of Srebp1 in BAT. SREBP was required in BAT for the thermogenic response to norepinephrine, and depletion of SREBP prevented maintenance of body temperature both during circadian cycles as well as during fasting of chronically cold mice. By contrast, deletion of REV-ERBα and β in BAT allowed mice to maintain their body temperature in chronic cold. Thus, the environmental challenge of prolonged noncircadian exposure to cold temperature induces circadian induction of SREBP1 that drives fuel synthesis in BAT and is necessary to maintain circadian body temperature during chronic cold exposure. The requirement for BAT fatty acid synthesis has broad implications for adaptation to cold.
Keywords: body temperature; brown adipose tissue; circadian; thermogenesis.
Conflict of interest statement
Conflict of interest statement: The sponsor declares a conflict of interest. M.A.L. is a scientific advisory board member for Pfizer and Lilly and receives research support from Pfizer unrelated to the present work. The authors declare a conflict of interest. M.A.L. is an advisory board member for Eli Lilly and Pfizer Inc., consultant to Novartis, and receives support from Pfizer for research not overlapping with the work reported here. Joseph Bass and M.A.L. are coauthors on a 2016 review article.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
